Portland biotech firm gets $500K loan from MTI

ImmuCell Corp. (Nasdaq: ICCC), a Portland biotech company that makes preventive health products for beef and dairy cattle, said it has received a $500,000 loan from the Maine Technology Institute that will help it boost its production capacity.

Production increases are planned for the company’s First Defense treatment for E. coli in newborn calves and to complete the development of Re-Tain, a treatment for a common disease in lactating cows that causes $2 billion in harm to the dairy industry annually.

The company is in the final stages of getting approval for Re-Tain from the U.S. Food and Drug Administration, according to ImmuCell’s website. It aims to ramp up production at a new 14,300-square-foot facility it has leased and renovated at 175 Industrial Way in Portland. Read more

Related Posts

Husson creates institute for leadership and workforce development

Husson University in Bangor has launched an institute dedicated to strategic leadership and workforce development training and education.  Founded by the...

21 February 2023

Swiss optics supplier acquires Portland-based Gray Optics

The acquisition of Gray Optics in Portland by a Swiss photonics firm expands the latter’s presence in the U.S. while allowing...

17 February 2023

ElleVet Sciences, the Leading Pet CBD+CBDA Brand in the United States, Expands into Europe 

PORTLAND, Maine, Feb. 15, 2023 /PRNewswire/ — ElleVet Sciences announced today that it is expanding its global reach with its new European Headquarters...

15 February 2023